Lu W - Search Results

1

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol.

Zhu H, Ding WJ, Wu R, Weng QJ, Lou JS, Jin RJ, Lu W, Yang B, He QJ. Zhu H, et al. Among authors: lu w. Cancer Invest. 2010 Jan;28(1):23-32. doi: 10.3109/07357900903095664. Cancer Invest. 2010. PMID: 19916747

2

CPT21, a novel compound with anti-proliferative effect against gastric cancer cell SGC7901.

Zhang B, Luo Y, Weng Q, He Q, Lu W, Yang B. Zhang B, et al. Among authors: lu w. Invest New Drugs. 2008 Dec;26(6):517-24. doi: 10.1007/s10637-008-9120-9. Epub 2008 Feb 19. Invest New Drugs. 2008. PMID: 18283417

3

Synergistic antitumor effect of TRAIL in combination with sunitinib in vitro and in vivo.

Ding W, Cai T, Zhu H, Wu R, Tu C, Yang L, Lu W, He Q, Yang B. Ding W, et al. Among authors: lu w. Cancer Lett. 2010 Jul 28;293(2):158-66. doi: 10.1016/j.canlet.2010.01.005. Epub 2010 Feb 6. Cancer Lett. 2010. PMID: 20137855

4

Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.

Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu W, He QJ, Yang B. Zhu H, et al. Among authors: lu w. Cancer Lett. 2010 Nov 28;297(2):155-64. doi: 10.1016/j.canlet.2010.04.030. Epub 2010 Jun 1. Cancer Lett. 2010. PMID: 20605676

5

Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells.

Zhu H, Yang W, He LJ, Ding WJ, Zheng L, Liao SD, Huang P, Lu W, He QJ, Yang B. Zhu H, et al. Among authors: lu w. PLoS One. 2012;7(12):e52333. doi: 10.1371/journal.pone.0052333. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284992 Free PMC article.

6

Potent antitumor activity of 10-methoxy-9-nitrocamptothecin.

Luo P, He Q, He X, Hu Y, Lu W, Cheng Y, Yang B. Luo P, et al. Among authors: lu w. Mol Cancer Ther. 2006 Apr;5(4):962-8. doi: 10.1158/1535-7163.MCT-05-0385. Mol Cancer Ther. 2006. PMID: 16648567

7

P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.

Zhang C, Zhu H, Yang X, Lou J, Zhu D, Lu W, He Q, Yang B. Zhang C, et al. Among authors: lu w. J Cancer Res Clin Oncol. 2010 Mar;136(3):437-45. doi: 10.1007/s00432-009-0674-5. Epub 2009 Sep 2. J Cancer Res Clin Oncol. 2010. PMID: 19727814

8

Antimetastatic activity of MONCPT in preclinical melanoma mice model.

Yang XC, Tu CX, Luo PH, Zhu H, Zhu DF, Wu HH, Zhou XL, Lu W, He QJ, Yang B. Yang XC, et al. Among authors: lu w. Invest New Drugs. 2010 Dec;28(6):800-11. doi: 10.1007/s10637-009-9323-8. Epub 2009 Sep 30. Invest New Drugs. 2010. PMID: 19789842

9

Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.

Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, He QJ, Yang B. Zhu H, et al. Among authors: lu w. J Pharmacol Exp Ther. 2010 Aug;334(2):489-99. doi: 10.1124/jpet.110.165654. Epub 2010 May 14. J Pharmacol Exp Ther. 2010. PMID: 20472666

10

Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells.

Zhao Y, Xue T, Yang X, Zhu H, Ding X, Lou L, Lu W, Yang B, He Q. Zhao Y, et al. Among authors: lu w. Toxicol Appl Pharmacol. 2010 Oct 1;248(1):20-7. doi: 10.1016/j.taap.2010.07.007. Epub 2010 Jul 15. Toxicol Appl Pharmacol. 2010. PMID: 20637791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,670 results

Search Page

Filters